Prof. Dr. Halil Murat AYDIN is the Founder of Meridian Biomaterials with over two decades of expertise in bioengineering, biomaterials, and medical device development. He has played a pivotal role in the advancement of tissue engineering, biodegradable polymeric materials, and injectable biomaterial technologies, and is recognized as a developer of a calcium hydroxyapatite (CaHA)-based injectable product introduced on a global scale.
Building on this legacy, Prof. Dr. Aydın leads the development of Xelestal+, a groundbreaking biostimulant platform and currently the only product of its kind worldwide. The product incorporates two proprietary technologies: Manganese-Substituted Apatite Lattice (MASAL™), where manganese ions integrated within the CaHA lattice provide enhanced fibroblast protection, and Micro-Scaled Resilient Array (MISRA™), a novel particle design that extends beyond conventional size ranges to maximize biostimulant performance. Together, these innovations position Xelestal+ at the forefront of biostimulant technology, shaping the future of regenerative and aesthetic treatments.
Under Prof. Dr. Aydın’s leadership, Meridian Biomaterials focuses on advancing next-generation biostimulants through innovative scientific approaches, precision engineering, and a strong commitment to safety, efficacy, and clinical relevance.